^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    TAK-012

    i
    Other names: allogeneic Vδ1 γδ T cell therapy, TAK-012, GDX012, Allogeneic variable delta 1 gamma-delta T cell cancer therapy
    Associations
    News
    Trials
    Company:
    Takeda
    Drug class:
    Immunomodulator, γδ TCR modulator
    Related drugs:
    Associations
    News
    Trials